IL17A and hepatocellular carcinoma: Guo et al. also provided evidence that infiltrating M2-TAMs were markedly elevated in the HCC TME, producing IL-17, a pro-inflammatory cytokine, and were augmented upon oxaliplatin treatment (Guo et al., 2017).